Foresite Capital, a healthcare growth equity firm, closed its Fund III, at $450m.
Foresite Capital Fund III will continue to execute the firm’s strategy of financing emerging leaders across all healthcare sectors in both the private and public markets. The vehicle invests in novel products, technologies and services that have the potential to improve patient outcomes while decreasing the cost and burden of human disease.
Led by Jim Tananbaum, founder and CEO, Christine Aylward, Matt Buten, Dorothy Margolskee, and Brett Zbar, and Chief Financial Officer Dennis Ryan, Foresite Capital is based in San Francisco, CA with an office in New York, NY.
With the close of this fund, the firm has more than $1 billion in assets under management.
FinSMEs
29/07/2015